Related Experiment Video

Updated: Jun 13, 2025

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

15.7K

Protective role of acetylcholine and the cholinergic system in the injured heart

Clara Liu Chung Ming1,2, Xiaowei Wang3,4,5, Carmine Gentile1,2

  • 1School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology Sydney, Sydney, NSW, Australia.

Iscience
|September 16, 2024
PubMed

Insights

Acetylcholine (ACh) plays a vital role in heart health and preventing cardiovascular diseases (CVDs). New strategies like stem cell therapy and gene therapy show promise for increasing ACh and regenerating heart tissue.

Area of Science:

  • Cardiovascular Science
  • Neurocardiology
  • Pharmacology

Background:

  • The heart possesses both neuronal and non-neuronal cholinergic systems.
  • Acetylcholine (ACh) is crucial for maintaining cardiac homeostasis.
  • Reduced ACh levels are linked to early cardiovascular disease (CVD) onset.

Purpose of the Study:

  • To review the multifaceted roles of the cholinergic system in cardiac function.
  • To evaluate current and novel strategies for modulating cardiac ACh levels.
  • To explore advanced therapeutic approaches for cardiac repair.

Main Methods:

  • Literature review of studies on the cardiac cholinergic system.
  • Analysis of existing interventions targeting ACh levels (e.g., vagus nerve stimulation, cholinesterase inhibitors).
  • Exploration of emerging regenerative strategies (stem cells, gene therapy, microRNAs, nanoparticles).

Main Results:

  • The cholinergic system, via ACh, is integral to cardiac homeostasis and offers protection against CVD.
  • Current methods to boost ACh have limitations.
  • Novel approaches like stem cell therapy, gene therapy, microRNAs, and nanoparticle delivery present promising alternatives.

Conclusions:

  • Restoring or enhancing cardiac ACh levels is a key therapeutic target for CVD.
  • Emerging regenerative strategies hold significant potential for treating injured heart tissue.
  • Further research into these novel ACh-modulating therapies is warranted for clinical translation.

Keywords:
Cardiovascular medicinePathophysiology

More Related Videos

Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System08:01

Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System

Published on: June 11, 2020

8.1K
Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System06:40

Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System

Published on: May 22, 2018

10.7K

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
638
Parasympathetic Signaling01:30

Parasympathetic Signaling

Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
1.8K
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.0K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.8K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
813
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
4.5K